It has been reported that circRNA could modulate immune responses in the tumor microenvironment of lung cancer and be involved in lung cancer progression—for instance, ciRS-7 interacts with miR-7 to modulate the expression of NF-κB, modulating the activities of immune cells and affecting the development of lung cancer (214, 215). This evidence concerns the gene NFKB1 and lung carcinoma.